US2004228933A1PendingUtilityA1
Method for normalizing insulin levels
Priority: Oct 26, 2001Filed: Jun 15, 2004Published: Nov 18, 2004
Est. expiryOct 26, 2021(expired)· nominal 20-yr term from priority
A61K 31/7012A61K 31/198
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention is directed to a dietary supplement which contains mannoheptulose. Mannoheptulose occurs naturally in avocado fruit. The dietary supplement and its method of use can lower serum insulin levels and lower a subject's weight. The dietary supplement in its disclosed form includes a controlled release system for mannoheptulose. The dietary supplement may also include one or more amino acids.
Claims
exact text as granted — not AI-modified1 . A solid oral dosage form to be swallowed, wherein said dosage form comprises mannoheptulose and a controlled release system.
2 . The oral dosage form of claim 1 , wherein said controlled release system is a delayed release system.
3 . The oral dosage form of claim 1 , wherein said controlled release system is a sustained release system.
4 . The oral dosage form of claim 1 , wherein said controlled release system comprises carboxymethylcellulose.
5 . A solid oral dosage form to be swallowed, wherein said oral dosage form comprises mannoheptulose, a controlled release system, and one or more amino acids.
6 . The oral dosage form of claim 5 , wherein one amino acid is glutamic acid.
7 . The oral dosage form of claim 5 , wherein one amino acid is aspartic acid.
8 . The oral dosage form of any one of claims 1 - 7 , wherein said oral dosage form comprises 10 mg-1000 mg of mannoheptulose.
9 . The oral dosage form of any one of claims 1 - 7 , wherein said oral dosage form comprises 50 mg-250 mg of mannoheptulose.
10 . (canceled)
11 . (canceled)
12 . (canceled)
13 . (canceled)
14 . (canceled)Join the waitlist — get patent alerts
Track US2004228933A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.